National Institutes of Health, 32128 [07-2873]
Download as PDF
32128
Federal Register / Vol. 72, No. 111 / Monday, June 11, 2007 / Notices
Licensing Status: Available for
exclusive or non-exclusive licensing.
Licensing Contact: Peter A. Soukas,
J.D.; 301/435–4646;
soukasp@mail.nih.gov.
Dated: June 4, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–11195 Filed 6–8–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meetings
rmajette on DSK8KYBLC1PROD with MISCELLANEOUS
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Cancer Institute Board of
Scientific Advisors.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors;
TARGET Ad Hoc Subcommittee Meeting.
Date: June 27, 2007.
Time: 7 p.m. to 9: 30 p.m.
Agenda: To discuss activities related to the
BSA TARGET Ad Hoc Subcommittee.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, Md 20814.
Contact Person: Malcolm M. Smith, PhD,
MD, Executive Secretary, Associate Branch
Chief, Pediatric Section, Clinical
Investigation Branch, Clinical Therapy
Evaluation Program, NCI, 6130 Executive
Blvd, EPN, 7th Floor, Rm. 7025, Bethesda,
MD 20852, 301–496–2522,
smithm@ctep.nci.nih.gov.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: June 28–29, 2007.
Time: June 28, 2007, 8 a.m. to 6 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review,
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Time: June 29, 2007, 8:30 a.m. to 1 p.m.
Agenda: Reports of Special Initiatives; RFA
and RFP Concept Reviews; and Scientific
Presentations.
VerDate Mar<15>2010
12:15 Mar 07, 2011
Jkt 223001
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Director, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Rm. 8001,
301–496–5147, grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID. driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: June 1, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2873 Filed 6–8–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal concerning individuals
associated with the grant applications,
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcholism Special
Emphasis Panel, Epigenetic Mechanisms in
the Neurobiology of Alcohol Tolerance and
Dependence. (RFA–AA–07–011 & AA–07–
012).
Date: July 16, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Beata Buzas, PhD,
Scientific Review Administrator, National
Institutes on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5635 Fishers
Lane, RM 3041, Rockville, MD 20852, 301–
443–0800, bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: June 1, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2872 Filed 6–8–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Chemical
Senses.
Date: June 27, 2007.
Time: 12 p.m. to 1:30 p.m.
E:\ERIC\11JNN1.SGM
11JNN1
Agencies
[Federal Register Volume 72, Number 111 (Monday, June 11, 2007)]
[Notices]
[Page 32128]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2873]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Cancer Institute Board of Scientific Advisors.
The meetings will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors; TARGET Ad Hoc Subcommittee Meeting.
Date: June 27, 2007.
Time: 7 p.m. to 9: 30 p.m.
Agenda: To discuss activities related to the BSA TARGET Ad Hoc
Subcommittee.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, Md 20814.
Contact Person: Malcolm M. Smith, PhD, MD, Executive Secretary,
Associate Branch Chief, Pediatric Section, Clinical Investigation
Branch, Clinical Therapy Evaluation Program, NCI, 6130 Executive
Blvd, EPN, 7th Floor, Rm. 7025, Bethesda, MD 20852, 301-496-2522,
smithm@ctep.nci.nih.gov.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: June 28-29, 2007.
Time: June 28, 2007, 8 a.m. to 6 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Program Review, Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Time: June 29, 2007, 8:30 a.m. to 1 p.m.
Agenda: Reports of Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD, Executive Secretary,
Director, Division of Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116 Executive Boulevard,
8th Floor, Rm. 8001, 301-496-5147, grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID.
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: June 1, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2873 Filed 6-8-07; 8:45 am]
BILLING CODE 4140-01-M